Bioactive Food Ingredients for Immune Health and Preventive Nutrition Market to Reach USD 129.76 Billion by 2032 as Daily Immune Support Moves into Mainstream Food, Beverage, and Clinical Nutrition

April 9, 2026 - According to Global Reports Store, the global Bioactive Food Ingredients for Immune Health and Preventive Nutrition Market is valued at USD 68.42 billion in 2025 and is projected to reach USD 129.76 billion by 2032, expanding at a CAGR of 9.56% during 2026-2032. The market is being strengthened by a durable shift toward proactive health management, where consumers increasingly use everyday nutrition to support resilience, recovery, and long-term wellbeing rather than relying only on reactive care. The report identifies probiotics as the leading ingredient segment and North America as the largest regional market. That direction is consistent with wider health trends: the World Health Organization says the global population aged 60 and older is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, while the U.S. National Institutes of Health notes that vitamins, minerals, herbal ingredients, and probiotics are among the diet supplement ingredients most closely associated with immune function support.

Request Exclusive Sample: https://www.globalreportsstore.com/request-sample/1277/

Market Overview and Size

This market is no longer best viewed as a narrow supplement niche. It is increasingly part of a broader nutrition platform spanning functional foods, beverages, daily supplements, and specialized clinical products. Global Reports Store's report page shows that the category is being shaped by ingredient systems that are easier to integrate into routine consumption and by a stronger preference for science-backed health positioning. In commercial terms, that matters because the market is benefiting from repeat-use formats rather than one-time or seasonal purchase behavior. The report's growth from USD 68.42 billion in 2025 to USD 129.76 billion by 2032 reflects that broader structural shift.

The health backdrop also supports the category's long-term relevance. NIH's Office of Diet Supplements says immune function depends in part on nutrients such as vitamin D and zinc, and also recognizes that herbal ingredients and probiotics may affect immune function. That strengthens the market case for vitamins and minerals, probiotics, plant extracts, and broader bioactive systems that can be positioned within preventive nutrition rather than only within conventional supplementation.

Market Dynamics

Preventive health is becoming a stronger food-and-nutrition spending driver

The strongest long-term driver is the shift from reactive care toward everyday preventive health. Global Reports Store frames the market around immune resilience and preventive nutrition, and that positioning is reinforced by demographic pressure. WHO's ageing outlook suggests a larger global population increasingly focused on resilience, healthy ageing, and nutrition-led support. For food, beverage, and ingredient companies, that means immune-oriented bioactives are becoming relevant across more life stages, not only in acute wellness moments.

Probiotics remain the market's leading commercial ingredient cluster

The report identifies probiotics as the largest ingredient segment, generating USD 18.72 billion in 2025, or 27.36% of total market revenue, and projecting to USD 35.94 billion by 2032. That leadership is commercially important because probiotics sit at the intersection of digestive health, microbiome science, and immune-related product positioning. NIH's probiotics fact sheet for health professionals also reflects how firmly the category has moved into evidence-led nutrition discussion rather than remaining a fringe wellness trend.

Micronutrients remain one of the market's most scalable growth pillars

Vitamins and minerals generated USD 15.28 billion in 2025, representing 22.34% of the market, according to Global Reports Store. That scale is easy to understand commercially: micronutrients are familiar to consumers, widely accepted across regulators and formulators, and easy to embed into supplements, beverages, sachets, and fortified foods. NIH specifically notes that vitamin D modulates immune function and that zinc plays a role in enhancing immune function, making this segment one of the most commercially accessible and scientifically recognizable parts of the market.

Clinical nutrition is emerging as the higher-value growth opportunity

One of the strongest opportunities lies in more medically positioned nutrition use cases. Global Reports Store values clinical nutrition at USD 10.75 billion in 2025 and identifies it as a high-growth area, while the report's executive scope explicitly highlights clinical nutrition and immune support as a leading expansion zone. That suggests the market's next phase is likely to be shaped not only by consumer packaged goods, but also by products with stronger clinical validation, condition-specific positioning, and healthcare-channel relevance.

Market Disruption

The market's main disruption is the move from broad wellness claims to evidence-backed, formulation-specific positioning. Global Reports Store points to regulatory compliance and product standardization as meaningful challenges, and that is consistent with what is happening across nutrition markets more broadly. Buyers increasingly expect validated claims, better bioavailability, clearer dosage logic, and stronger scientific substantiation. In practical terms, this favors suppliers that can combine ingredient science, formulation stability, and regulatory discipline rather than relying on brand language alone.

Recent Developments

Recent industry activity supports that transition toward higher-value, more validated immune-health ingredients. dsm-firmenich said its Health, Nutrition & Care business delivered 3% organic sales growth in 2025 with a 19.4% adjusted EBITDA margin, while also expanding its HMO portfolio and advancing synbiotic solutions for early-life nutrition. ADM highlighted that its ES1 postbiotic won the Immune & Gut Health Ingredient category at the 2025 Vitafoods Europe Innovation Awards. Kerry has continued to position Wellmune around clinically supported immune health, stating that the ingredient is backed by more than 50 studies and remains relevant across life stages from children to older adults.

Market Segmentation

According to Global Reports Store, the market is segmented by Ingredient Type, Application, Form, End User, and Region. Within ingredients, the strongest revenue base remains concentrated in probiotics, vitamins and minerals, and plant extracts. The report values plant extracts at USD 12.96 billion in 2025, or 18.94% of revenue, while prebiotics account for USD 9.84 billion, omega fatty acids for USD 6.78 billion, and bioactive peptides for USD 4.84 billion. This mix shows a market that is already diversified, but still anchored by scientifically familiar ingredients with broad formulation compatibility.

By application, functional foods are the largest segment at USD 24.31 billion in 2025 and are projected to reach USD 46.52 billion by 2032. Diet supplements generated USD 19.64 billion, while functional beverages generated USD 13.72 billion. This breakdown matters because it shows the category's center of gravity is in habitual-use formats. The market is not relying on one delivery channel; it is expanding across multiple consumer routines, which supports stronger long-term demand resilience.

Regional Analysis
North America

Global Reports Store identifies North America as the leading market, generating USD 24.86 billion in 2025, or 36.34% of global revenue, and projecting to USD 45.92 billion by 2032. The report attributes that leadership to stronger consumer awareness, developed healthcare infrastructure, and higher product innovation intensity. North America is also where science-led diet supplement and functional food positioning tends to commercialize quickly, which helps explain why it remains the market's benchmark region.

Europe

Europe generated USD 19.74 billion in 2025, equal to 28.86% of global revenue. Global Reports Store notes that the region's strength comes from regulatory frameworks and strong demand for natural and organic products. In practical terms, Europe remains attractive because ingredient quality, traceability, and scientific validation tend to matter more in premium nutrition segments, which suits immune-focused bioactive products well.

Asia-Pacific

Asia-Pacific accounted for USD 16.82 billion in 2025, or 24.58% of the market, and is projected to reach USD 34.63 billion by 2032. The source links that growth to rising disposable income, urbanization, and acceptance of functional foods. The region also benefits from stronger interest in preventive nutrition and from demographic change, which should continue to expand demand for everyday health-support ingredients.

Buy This Exclusive Report: https://www.globalreportsstore.com/checkout/1277/

Company Profile

dsm-firmenich

dsm-firmenich remains one of the most relevant companies in this market. Its Health, Nutrition & Care business reported 3% organic sales growth in 2025 with a 19.4% adjusted EBITDA margin, and the company highlighted expansion of its HMO portfolio, synbiotic solutions, and algal omega-3 business. That gives dsm-firmenich strength across probiotics, early-life nutrition, omega ingredients, and science-led immune and gut-health positioning.

Kerry Group

Kerry reported €6,758 million in revenue and €1,208 million in EBITDA for 2025, and said it extended its nutritional reach to 1.46 billion consumers. Its immune-health relevance is reinforced by Wellmune, which Kerry describes as a clinically supported yeast beta glucan postbiotic backed by 50+ studies. That makes Kerry particularly important in functional food and beverage formulations where immune positioning must work alongside taste and product experience.

BASF SE

BASF's Nutrition & Care segment generated €6,509 million in sales in 2025, including €1,744 million from Nutrition & Health. BASF remains important in this market through vitamins, carotenoids, and human nutrition ingredients, and the company's human-nutrition portfolio specifically highlights ingredients such as vitamin D3 and vitamin E, both of which it positions in relation to immune support.

ADM

ADM remains strategically relevant because its Nutrition business includes probiotics, prebiotics, postbiotics, botanical extracts, enzymes, and other specialty ingredients, and management said Nutrition is expected to continue its trajectory of stronger organic growth. Its recent visibility in immune-related ingredients improved further when ES1 postbiotic won a 2025 Vitafoods innovation award in the Immune & Gut Health Ingredient category.

Analyst View

According to Global Reports Store, the Bioactive Food Ingredients for Immune Health and Preventive Nutrition Market is moving into a more disciplined and higher-value phase. Probiotics should remain the leading ingredient group, micronutrients will continue to provide the broadest mainstream adoption base, and clinical nutrition is likely to capture a rising share of premium growth. The companies best placed to gain share are likely to be those that combine scientific substantiation, formulation flexibility, regulatory readiness, and format innovation across foods, beverages, and supplements. In this market, immune health is no longer just a claim. It is becoming a platform for broader preventive nutrition strategy.

Media Contact
Global Reports Store
Office No. 301, Sairam IT Park, Hadapsar, Pune 411028
Email: sales@globalreportsstore.com

About Global Reports Store

Global Reports Store provides market research and advisory support across food and beverages, healthcare, technology, materials, energy, and industrial sectors. Its studies are designed to support market entry, product strategy, competitive benchmarking, and commercial decision-making through structured, decision-ready research.

This release was published on openPR.